Success Stories: EB-1A Petition Approved in 3 Days for Pharmacology Research Associate in Indiana Who Has Been Cited 156 Times
Client’s Testimonial:
“Thank you very much, lawyer.”
On September 21th, 2017, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Associate in the Field of Pharmacology (Approval Notice).
General Field: Pharmacology
Position at the Time of Case Filing: Research Associate
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Indiana
Approval Notice Date: September 21th, 2017
Processing Time: 3 days (Premium Processing Requested)
Case Summary:
With a doctoral degree in pathology and pharmacology combined with ample work experience in the same field, a recent client of ours was equipped with the credentials to ensure that the processing his EB-1A (Alien of Extraordinary Ability) petition was smooth sailing. Besides obtaining a Ph.D. and partaking in groundbreaking fieldwork, he has also achieved other feats that qualified him for this I-140 category, some of which included the following:
Research Work & Publications:
Our client has been a part of numerous research projects that aim at managing and mitigating the damage caused by metabolic and neurodegenerative disorders through an improved understanding of the molecular mechanisms that cause disease. The result of these studies include an impressive 16 peer-reviewed scientific articles cited 156 times at the time of filing the petition.
Review Work:
Our client also fulfilled another EB1A criteria laid down by the USCIS which requires the petitioner to serve in the capacity of a judge or reviewer. He has regularly reviewed scientific papers—16 papers at the time of filing—for reputable journals in the field, and thus, has established himself as an active member of the research community.
The fact that our client’s research is of immense value in managing diabetes, obesity, and Alzheimer’s and other such neurodegenerative conditions was also recognized by various experts in the field. A handful of these experts agreed to contribute letters of recommendation in support of our client’s EB1A petition, and the two statements listed below were extracted from a couple of these letters:
“As treating Alzheimer’s comes at a tremendous cost to the United States, the medical and economic value of [Client]’s work cannot be understated.”
“The proven results deriving from [Client]’s research demonstrate that he is a matchless presence in the field of pharmacology. There is no doubt that [Client] is among the best in his scientific territory, and his established position as one of the most advanced in his field necessitates his continued research.”
With the help of Premium Processing, we received petition approval in just 3 days (instead of 4-9 months). We are extremely pleased that our hard work resulted in a win, and we thank our client for hiring us to represent his EB1A case.